Dohan Ehrenfest DM, Vazquez L, Park YJ, Sammartino G, Bernard JP
presents with severe, persistent abdominal pain radiating to the back
Specific Brain Cells Are Sending the Yuck Signal Certain neurons in your brainstem activate when GLP-1 meds are in your system
Optimizing patient selection for tirzepatide therapy Based on the SURMOUNT-OSA population, candidates for tirzepatide therapy are those with obesity defined as BMI 30
The FDA and major gastroenterology societies have not identified gallbladder removal as a barrier to GLP-1 use
Nutrition and lifestyle support during GLP-1 therapy Whether you maintain brand name coverage, switch to compounded alternatives, or adjust your protocol due to cost constraints, nutrition plays a critical role in GLP-1 treatment outcomes